liver cancer
37 projects
HEIndividual fellowship2027–2028Italy
RESIST-CCA · Unravelling Malignant Cholangiocyte Subpopulations that Drive Chemoresistance in Cholangiocarcinoma
HEIndividual fellowship2027–2029Spain
IRM · Glutaminase Isoenzymes: Gatekeepers of Bioenergetics, Immunity, and Tumor Microenvironment in Diabetes-Induced Hepatocellular Carcinoma
HEIndividual fellowship2026–2028Germany
EpiGen-LC · Epigenetic and Genetic interplay in Liver Cancer
HEIndividual fellowship2025–2027Belgium
DETECTIVE · DEmystifying Targets in Endothelial Cells for anti-Tumor Immunity improVEments
H2020Individual fellowship2021–2023France
Multi-IF · Multicolor Fluorescent Ultrashort Carbon Nanotubes for Multiplexed immunofluorescence in Cancer Diagnostics
H2020Doctoral network2019–2022Netherlands
ElectroPros · Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments.
3 partners · 2 countries
H2020Individual fellowship2019–2021Switzerland
mTORmorS · Role of mTOR signaling dysregulation in the tumor suppressor networks in hepatocellular carcinoma
H2020Staff exchange2018–2022France
COCLICAN · COllaborative Consortium for the early detection of LIver CANcer
8 partners · 5 countries
H2020Doctoral network2017–2021Spain
VIRO-FLOW · Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors
2 partners · 2 countries
H2020Individual fellowship2017–2019Switzerland
ADVaNCE · ADVerse outcome Network for non-mutagenic CarcinogEns
H2020Individual fellowship2017–2020Denmark
MiRCHOL · Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer
H2020Doctoral network2017–2021Portugal
Foie Gras · Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease
14 partners · 8 countries
H2020Individual fellowship2016–2018United Kingdom
EXNADMINA · EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease
H2020Doctoral network2016–2021Norway
HiPerNav · High Performance Soft-tissue Navigation
14 partners · 6 countries
H2020Individual fellowship2016–2018Italy
ENVERESP · Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity
H2020Individual fellowship2016–2018United Kingdom
EPILIPRO · Elucidating the role of Arid1a in adult liver
H2020Individual fellowship2016–2018Denmark
EpiLIVER · Characterization and implications of DNA damage response in liver cancer
H2020Individual fellowship2016–2017Belgium
REZONABLE · Regeneration and zonation by ZEB2 of Liver Endothelium
H2020Individual fellowship2016–2018United Kingdom
mini-liver SCCS · Human “mini-liver” stem cell culture systems: from mechanisms behind liver cancer origin and recurrence to new therapeutic treatments
H2020Individual fellowship2015–2017Belgium
LiVirIn · 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction
H2020Individual fellowship2015–2018Spain
TARGEPILIVER · Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.
H2020Individual fellowship2015–2017Greece
EpiNKT · Transcriptional and epigenetic control of innate-like T lymphocyte development
FP7Individual fellowship2014–2016Sweden
INTERDRUG · Epigenetic mechanisms underlying inter-individual differences in drug response and hepatic disease
FP7Individual fellowship2014–2016United Kingdom